Adult β-thalassemic patients with chronic hepatitis C: Long-term efficacy of α-IFN treatment

European Journal of Internal Medicine

Volumn 11, Issue 3, 2000, Pages 161-164

  Labropoulou Karatza, Chryssoula ^a   Goritsas, Consantin ^a   Fragopanagou, Helen ^a   Matsouka, Panagiota ^a   Spiliopoulou, Iris ^a   Barbatis, Calypso ^b  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b RED CROSS HOSPITAL   (Greece)

Author keywords

Interferon; Thalassemia major; Hepatitis C

Indexed keywords

ALPHA INTERFERON;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; BETA THALASSEMIA; CHRONIC HEPATITIS; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HEPATITIS C; HUMAN; INFECTION RISK; MALE; TREATMENT OUTCOME;

EID: 0034089903     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(00)00081-9     Document Type: Article

References (21)

1. Angelucci E. Antibodies to hepatitis C virus in thalassemia. Hematologica. 79:1994;353.
2. Carithers R.L. Jr., Emerson S.S. Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials. Hepatology. 26:(Suppl 1):1997;83S-88S.
3. Barton A.L., Banner B.F., Cable E.E., Bonkovsky H.L. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. Am J Clin Pathol. 103:(4):1995;419-424.
4. Olynyk J.K., Reddy K.R., Di Biscelie A.M., Jeffers L.J., Parker T.I., Radick J.L., et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology. 108:(4):1995;1104-1109.
5. Farinati R.F., Cardin R., De Maria N., Libera G.D., Marafin C., Lecis E., et al. Iron storage, lipid peroxidation and glutathion turnover in chronic anti-HCV positive hepatitis. J Hepatol. 22:1995;449-456.
6. Ishak K., Baptista A., Bianci L., Callea L., De Groote J., Gudat F., et al. Histological grading and staging of chronic hepatitis. J Hepatol. 22:1995;696-699.
7. Rowe J.W., Wands J.R., Mezey E., et al. Familial hemochromatosis: characteristics of precirrhotic stage in a large kindred. Medicine. 56:1977;197-211.
8. Clemente M.G., Congia M., Lai M.E., Lilliu F., Lampis R., Frau F., et al. Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion dependent patients with thalassemia major and chronic hepatitis C. J Pediatr. 125:(1):1994;123-128.
9. Wonke B., Donohue S.M., Hoffbrand A.V., Scheuer P.J., Brown D., Dusheiko G. Recombinant alpha 2b interferon (IFN) in the treatment of chronic hepatitis C disease in thalassemia major (TM). Bone Marrow Transplant. 12:(Suppl 1):1993;24-25.
10. Di Marco V., Lo Iacono O., Capra M., Grutta S., Ciaccio C., Gerardi C., et al. Alpha interferon treatment of chronic hepatitis C in beta-thalassemia. Gut. 34:(2 Suppl):1993;S142-143.
11. Panel statement: management of hepatitis C. Hepatology. 26:(Suppl 1):1997;2S-10S.
12. Tong M.J., Blatt L.M., McHutchinson J.G., Co R.L., Conrad A. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison. Hepatology. 26:1997;1640-1645.
13. McHutchinson J.G., Blatt L.M., Sedghi-Vaziri A., Russell J., Schmid P., Conrad A. Is there an optimal time to measure quantitative HCV RNA to predict non-response following interferon treatment for chronic HCV infection? J Hepatol. 29:1998;362-368.
14. Di Marco V., Iacono L., Almasio P., Ciaccio M., Capra M., Rizzo R., et al. Long term efficacy of α-interferon in β-thalassemics with chronic hepatitis C. Blood. 90:(6):1997;2207-2212.
15. Banner B.F., Barton A.L., Cable E.E., Smith L., Bonkovsky H.L. A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C. Mod Pathol. 8:(3):1995;232-238.
16. Ikura Y., Morimot H., Johmura H., Fukui M., Sakurai M. Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C. Am J Gastroenterol. 91:1996;1367-1373.
17. Kikuyama M., Kobayashi Y., Kawasaki T., Yoshimi T. Hepatic lipid peroxidation in chronic hepatitis C. Hepatology. 24:1995;275A. Abstract.
18. Bacon B.R., Britton R.S. Hepatic injury in chronic iron overload: role of lipid peroxidation. Chem-Biol Interact. 70:1989;183-226.
19. Rudd M.J., Good M.F., Chapman D.E., Powell L.W., Halliday J.W. Clonal analysis of the effect of iron on human cytotoxic and proliferating T lymphocytes. Immunol Cell Biol. 68:1990;317-324.
20. Bonkovsky L.H., Banner B.F., Rothman A.L. Iron and chronic viral hepatitis. Hepatology. 25:(3):1997;759-768.
21. Zeuzem S., Schmidt J.M., Lee J.-H., von Wagner M., Teuber G., Roth W.R. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover. Hepatology. 28:(1):1998;245-252.